ARCHIVES

NIC Grants Appeals Process Explained

This article is from The Cancer Letter archive.

Vol. 11 No. 16 | April 19, 1985

Download PDF Visit The Full Archive

Related Articles

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980

In Brief: Michael Boyd Named New DTP Director; Saunders Retires; Michael Friedman New Chief Of CIB

October 7, 1983

Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review

January 13, 1978

High-Dose Chemo Can Cure Rare Pediatric Brain Tumor

February 25, 2005

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

The Varmus Era: Controversy Continues

January 6, 1995